Press releases

Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio

Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit

Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leaders

Biocartis Partners with Lilly to Explore Biomarker Testing for NSCLC Patients using the Idylla™ Platform

Biocartis and HiloProbe to Collaborate on Colorectal Cancer Test

Biocartis and APIS Assay Technologies Sign Collaboration to Develop and Commercialise a Breast Cancer Subtyping Test on the Idylla™ platform

Biocartis announces the US FDA 510(k) clearance for the Idylla™ MSI Test

Biocartis announces change in Board composition

Biocartis announces the launch of the first assay developed with the new Idylla™ FLEX technology

New Idylla™ EGFR Study Shows Reduction of Time-to-Treatment by 48% for Lung Cancer Patients